Protein Trafficking and Alzheimers Disease

Author(s): Kengo Uemura, Akira Kuzuya, Shun Shimohama

Journal Name: Current Alzheimer Research

Volume 1 , Issue 1 , 2004

Become EABM
Become Reviewer
Call for Editor


Mutations in presenilin 1 (PS1) cause early-onset familial Alzheimers disease (FAD). Although FAD accounts for less than 5% of all cases of Alzheimers disease (AD), extensive analyses of PS1 function have elucidated an important neuronal mechanism underling AD pathogenesis. PS1 is considered to be an essential component of γ-secretase, which cleaves amyloid precursor protein (APP) at the transmembrane region and releases amyloid β (Aβ) peptide. In addition to this well-documented function, a growing amount of evidence suggests that PS1 is involved in the intracellular trafficking of selected membrane proteins (i.e. APP, nicastrin, trkB, telencephalin). Recently, we have also shown that PS1 is involved in the trafficking of N-cadherin from the endoplasmic reticulum to the plasma membrane via the microtubule network. N-cadherin is localized at the synaptic junctional complex, providing an adhesive force across the synaptic cleft, and the its regulation is crucial for the neuron to exert its specific function, i.e. synaptic activity. In a mature neuron, polarized targeting of proteins from the cell body to the axonal and dendritic processes is essential for its proper function, especially, for the maintenance of synaptic function. Alterations in protein transport caused by a dysfunction in PS1 could lead to a disturbance in synaptic transmission and finally to neurodegeneration. This article will review the current knowledge of PS1 function in protein trafficking and discuss its potential role in AD pathogenesis.

Keywords: Alzheimer disease, Presenilin, Amyloid Precursor Protein, Amyloid b peptide, Protein Trafficking

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Page: [1 - 10]
Pages: 10
DOI: 10.2174/1567205043480528

Article Metrics

PDF: 30